Roswell Park Cancer Institute Clinical Trials 2022

Trials at this site

DOX-SL vs. Chemotherapy for Kaposi Sarcoma

18+

All Sexes

Buffalo, NY

This trial is testing a new cancer treatment for AIDS-related Kaposi's sarcoma, comparing it to an established treatment. They are testing for safety and effectiveness.

Phase 3

Waitlist Available

Has No Placebo

Learn More

Roswell Park Cancer InstituteSequus Pharmaceuticals

Standard Care + Photodynamic Therapy for Brain Tumor

18+

All Sexes

Buffalo, NY

This trial is studying adding photodynamic therapy to surgery, radiation therapy, and chemotherapy in treating patients with newly diagnosed or recurrent malignant supratentorial gliomas.

Phase 3

Waitlist Available

Has No Placebo

Learn More

Roswell Park Cancer InstituteFred W. Hetzel, PhD, JD

Nitrocamptothecin for Pancreatic Cancer

18+

All Sexes

Buffalo, NY

This trial is comparing the effectiveness of nitrocamptothecin to other chemotherapy drugs for cancer of the pancreas.

Phase 3

Waitlist Available

Has No Placebo

Learn More

Roswell Park Cancer InstituteLawrence A. Romel, MSAstex Pharmaceuticals, Inc.

Combination Chemotherapy + Monoclonal Antibody for Acute Myeloid Leukemia

18+

All Sexes

Buffalo, NY

This trial is comparing the effectiveness of chemotherapy with or without monoclonal antibody therapy for treating patients with refractory or relapsed acute myelogenous leukemia.

Phase 3

Waitlist Available

Has No Placebo

Learn More

Roswell Park Cancer InstituteDaniel Levitt, MD, PhDFacet Biotech

Chemotherapy + Monoclonal Antibody Therapy for Non-Hodgkin's Lymphoma

18+

All Sexes

Buffalo, NY

This trial is comparing two different ways of treating non-Hodgkin's lymphoma with chemotherapy, using either one monoclonal antibody or two monoclonal antibodies.

Phase 3

Waitlist Available

FDA Approved Drug

Learn More

Roswell Park Cancer InstituteOliver W. Press, MD, PhD

Chemotherapy Regimens for Colorectal Cancer

18+

All Sexes

Buffalo, NY

This trial will compare three chemotherapy regimens to see which is more effective in treating metastatic colorectal cancer.

Phase 3

Waitlist Available

Has No Placebo

Learn More

Roswell Park Cancer InstituteMace L. Rothenberg, MD, FACPSanofi

Combination Chemotherapy + IM-862 for Ovarian Cancer

18+

Female

Buffalo, NY

This trial is studying IM-862 to see how well it works in combination with standard chemotherapy in treating patients with ovarian or primary peritoneal cancer.

Phase 2

Waitlist Available

Has No Placebo

Learn More

Roswell Park Cancer InstitutePamela Paley, MDCytran

View All Trials at Roswell Park Cancer Institute

Is this your site?

Every week patients are viewing your profile. Claim your page to easily update information, respond to patients, and more!

Claim Profile